KEYNOTE-061: Response to subsequent therapy following second-line pembrolizumab or paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma

Yazar
Mandala, M.
Yoon, H.
Fuchs, C.
ÖZGÜROĞLU, Mustafa
Bang, Y.
Di Bartolomeo, M.
Ryu, M.
Fornaro, L.
Olesinski, T.
Caglevic, C.
Chung, H.
Muro, K.
Van Cutsem, E.
Elme, A.
Thuss-Patience, P.
Chau, I.
Ohtsu, A.
Wang, A.
Bhagia, P.
Lin, J.
Shih, C.
Shitara, K.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/4291
https://doi.org/10.1016/j.annonc.2020.04.065
Koleksiyonlar